글로벌 환각제 시장 – 2031년까지의 산업 동향 및 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Pharmaceutical Global Psychedelic Drugs Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

글로벌 환각제 시장 – 2031년까지의 산업 동향 및 예측

  • Pharmaceutical
  • Upcoming Report
  • Apr 2024
  • Global
  • 350 Pages
  • 테이블 수: 220
  • 그림 수: 60
지금 구매 지금 구매

Global Psychedelic Drugs Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Diagram 예측 기간
 2024 –2031
Diagram 시장 규모(기준 연도)
 USD 2.71 Billion
Diagram 시장 규모(예측 연도)
 USD 7.35 Billion
Diagram 연평균 성장률
 %
Diagram주요 시장 플레이어
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
잠금 해제 요청

>글로벌 환각제 시장, 출처(합성 및 천연), 유형(감정치료제, 해리제 및 기타), 약물(감마-하이드록시뷰티르산, 케타민, 실로시빈, 리저산 디에틸아미드(LSD), 3,4-메틸에네디옥시메스암페타민 및 기타), 응용 분야(발작성 졸음증, 치료 저항성 우울증, 주요 우울 장애, 아편 중독, 외상 후 스트레스 장애 및 기타), 투여 경로(경구, 흡입 및 주사), 최종 사용자(병원, 전문 클리닉, 홈 케어 및 기타), 유통 채널(병원 약국, 소매 약국 및 온라인 약국) - 업계 동향 및 2031년까지의 예측.

환각제 시장

환각제 시장 분석 및 규모

환각제 시장에는 공감물질, 해리물질 등으로 분류되는 다양한 물질이 포함됩니다. MDMA와 같은 공감물질은 공감과 사교성을 증가시킬 수 있는 반면, 케타민과 같은 해리물질은 현실과의 분리감을 만들어낼 수 있습니다. 실로시빈 버섯과 LSD와 같은 다른 환각제는 지각과 인지를 바꿀 수 있습니다.

글로벌 환각제 시장 규모는 2023년에 27억 1,000만 달러로 평가되었으며, 2031년까지 73억 5,000만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 13.3%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

보고서 메트릭

세부

예측 기간

2024년부터 2031년까지

기준 연도

2023

역사적 연도

2022 (2016-2021년까지 사용자 정의 가능)

양적 단위

매출은 10억 달러, 볼륨은 단위, 가격은 10억 달러

다루는 세그먼트

출처(합성 및 천연), 유형(공감작용제, 해리제 및 기타), 약물(감마-하이드록시뷰티르산, 케타민, 실로시빈, 리저산 디에틸아미드(LSD), 3,4-메틸에네디옥시메스암페타민 및 기타), 적용(발작성 졸음증, 치료 저항성 우울증, 주요 우울 장애, 아편 중독, 외상 후 스트레스 장애 및 기타), 투여 경로(경구, 흡입 및 주사), 최종 사용자(병원, 전문 클리닉, 홈 케어 및 기타), 유통 채널(병원 약국, 소매 약국 및 온라인 약국)

적용 국가

미국, 캐나다, 멕시코, 독일, 프랑스, ​​영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 유럽 기타 지역, 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀, 아시아 태평양 기타 지역, 사우디 아라비아, UAE, 남아프리카, 이집트, 이스라엘, 중동 및 아프리카 기타 지역, 브라질, 아르헨티나, 남미 기타 지역

시장 참여자 포함

Jazz Pharmaceuticals, Inc.(미국), Janssen Pharmaceuticals, Inc.(미국), Hikma Pharmaceuticals PLC(영국), Compass(미국), Verrian(독일), Pfizer Inc.(미국), F. Hoffmann-La Roche Ltd(스위스), Avadel(아일랜드), Celon Pharma SA(폴란드), Cybin Corp.(캐나다), GH Research(아일랜드), Entheon Biomedical Corp(캐나다), PharmaTher Holdings Ltd.(인도), NRx Pharmaceuticals, Inc.(미국), Usona Institute(미국)

시장 기회
  • 연구 자금 증가
  •  학계와 산업 간의 협력

시장 정의

환각제는 지각, 기분, 인지에 변화를 일으킬 수 있는 물질로, 종종 강렬한 주관적 경험을 초래합니다. 이러한 화합물의 사례로는 실로시빈(특정 버섯에서 발견), LSD, MDMA가 있습니다. 이들은 주로 뇌의 세로토닌 수용체를 표적으로 삼으며, 특히 감독 환경에서 사용할 때 정신 건강 장애를 치료하는 데 있어 잠재적인 치료적 이점에 대해 조사 중입니다.                    

환각제 시장 동향

운전자

  • 환각제 치료에 대한 지지 증가

의료 분야는 우울증, PTSD, 중독과 같은 질환에 대한 실로시빈과 MDMA와 같은 물질의 치료적 가능성을 입증하는 수많은 임상 시험 에 힘입어 환각제 치료를 점점 더 수용 하고 있습니다. 의료 전문가와 규제 기관 사이에서 이러한 진화하는 태도는 환각제 지원 치료가 기존 의료 접근 방식에 더 광범위하게 통합되도록 촉진하여 상당한 시장 확장을 촉진하고 있습니다.

  • 환각제 합법화 및 범죄 해제를 향한 전 세계적 변화 

전 세계 정부는 환각제에 대한 정책을 재평가하고 있으며, 정신 건강 장애 치료에 있어서 환각제가 가지는 치료적 잠재력을 인정하고 있습니다. 이러한 변화에는 소지를 비범죄화하고 심지어 의료 및 오락적 사용을 합법화하려는 움직임이 포함됩니다. 이러한 정책 변화는 시장에서 연구, 개발 및 상용화를 위한 새로운 기회를 창출하고 시장 성장을 촉진하고 있습니다.

기회

  • 학계와 산업 간의 협력

학술 기관은 과학적 연구와 전문 지식을 제공하는 반면, 산업 파트너는 약물 개발, 제형 및 상용화를 위한 리소스와 통찰력을 제공합니다. 이러한 협력은 과학적 발견을 혁신적인 치료법으로 가속화하여 시장 수요가 증가하는 가운데 두 부문 모두에 수익성 있는 기회를 제공합니다.

  • 연구 자금 증가

증가하는 연구 자금은 환각제 화합물의 치료적 응용, 안전 프로필 및 작용 메커니즘에 대한 광범위한 과학적 조사를 용이하게 합니다. 이러한 재정 지원은 새로운 약물 후보의 식별을 촉진하고 기존 치료법을 개선하여 공공 및 민간 투자를 유치하고 시장 성장과 확장을 촉진합니다.

제약/도전

  • 문화적 장애물

In areas dominated by conservative values or where the use of psychedelic drugs contradicts cultural norms or religious beliefs, the acceptance of these substances may be limited. This lack of acceptance could lead to reduced demand for psychedelic therapies, decreased willingness among healthcare professionals to prescribe them, and difficulties in regulatory approval processes, which can be a challenge for the market. 

  • Misuse and Public Safety Issues

Misuse, whether recreational or self-administered without medical supervision, can lead to adverse effects such as psychological distress or worsening of underlying mental health conditions. These events lead to doubt among regulators, healthcare professionals, and the public, disrupting the widespread acceptance of psychedelic therapies.

This psychedelic drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the psychedelic drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In September 2023, Cybin Inc. revealed a strategic partnership with Fluence, a renowned provider of continuing education in psychedelic therapy. This collaboration aims to bolster the expansion of the EMBARK training program for the CYB003 phase 3 trial
  • In October 2022, Numinus Wellness Inc., a leading mental health care company, launched a pioneering program offering Ketamine for treating chronic and serious medical conditions. Initially, this groundbreaking program was introduced in Numinus' clinics situated in Utah, British Columbia, and Quebec

Psychedelic Drugs Market Scope

The psychedelic drugs market is segmented on the basis of source, type, drugs, application, route of administration, end-user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

  • Synthetic
  • Natural

Type

  • Empathogens
  • Dissociatives
  • Others

Drugs

  • Gamma-Hydroxybutyric Acid
  • Ketamine
  • Psilocybin
  • Lysergic Acid Diethylamide (LSD)
  •  3,4-MethylEnedioxyMethamphetamine
  • Others

Application

  • Narcolepsy
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Opiate Addiction
  • Post-Traumatic Stress Disorder
  • Others

 Route of Administration

  • Oral
  • Inhalation
  • Injectable

End-User

  • Hospital
  • Speciality Clinics
  • Homecare
  • Others

 Distribution Channel

  • Hospitals Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Psychedelic Drugs Market Regional Analysis/Insights

The psychedelic drugs market is analyzed and market size insights and trends are provided by country, source, type, drugs, application, route of administration, end-user, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is expected to dominate the market due to the region's high prevalence of mental disorders, and ongoing research and development efforts drive market growth. This sustained leadership highlights North America's crucial role in influencing the direction of the global psychedelic drugs market.

Asia-Pacific is expected to witness significant growth during the forecast period due to expanding healthcare infrastructure and growing public awareness. As the region invests in mental health services and education, along with increasing acceptance of psychedelic therapies, it is emerging as a key contributor to the market's global expansion and development.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The psychedelic drugs market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for psychedelic drugs market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the psychedelic drugs market. The data is available for historic period 2016-2021.

Competitive Landscape and Psychedelic Drugs Market Share Analysis

환각제 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

  • Jazz Pharmaceuticals, Inc. (미국),
  • Janssen Pharmaceuticals, Inc. (미국)
  • 히크마 제약(영국)
  • 나침반(미국)
  • 베리안(독일)
  • 파이저 주식회사(미국)
  • F. 호프만-라 로슈 유한회사(스위스)
  • 아바델(아일랜드)
  • 셀론 파마 SA.(폴란드)
  • Cybin Corp. (캐나다)
  • GH Research (아일랜드)
  • Entheon Biomedical Corp(캐나다)
  • PharmaTher Holdings Ltd. (인도)
  • NRx Pharmaceuticals, Inc. (미국)
  • Usona Institute (US)양식 상단

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL Psychedelic drugs MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type of Psychedelic drugs LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET APPLICATION COVERAGE GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. epidemiology
  6. REGULATORY FRAMEWORK: GLOBAL PSYCHEDELIC DRUGS MARKET
    1. REGULATORY SCENARIO IN INDIA
    2. REGULATORY SCENARIO IN UAE
    3. REGULATORY SCENARIO IN AFRICA
    4. REGULATORY SCENARIO IN THE U.S.
    5. REGULATORY SCENARIO IN BRAZIL
    6. REGULATORY SCENARIO IN THE U.K.
  7. Pipeline analysis
  8. market overview
    1. DRIVERS
      1. GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION
      2. INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS
      3. RISING AWARENESS TOWARDS MENTAL HEALTH
      4. ONGOING CLINICAL TRIALS
      5. RISE IN PRODUCT APPROVALS
    2. RESTRAINTS
      1. STRINGENT REGULATIONS FOR PSYCHEDELIC DRUGS
      2. HIGH COST OF PSYCHEDELIC DRUGS
      3. PATENT EXPIRY OF PSYCHEDELIC DRUGS
    3. OPPORTUNITIES
      1. INCREASING R&D ACTIVITIES IN PSYCHEDELIC DRUGS
      2. BREAKTHROUGH THERAPY DESIGNATION BY REGULATORY AUTHORITY
      3. UPCOMING REHABILITATION CENTERS
      4. AVAILABILITY OF CERTIFIED HEALTHCARE PROFESSIONALS
    4. CHALLENGES
      1. SIDE EFFECTS ASSOCIATED WITH PSYCHEDELIC DRUGS
      2. RISE IN ALTERNATIVES
      3. OTHER TREATMENT OPTIONS
  9. COVID-19 IMPACT ON GLOBAL PSYCHEDELIC DRUGS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  10. global psychedelic drug market, BY source
    1. overview
    2. SYNTHETIC
    3. natural
  11. global psychedelic drugs MARKET, BY type
    1. overview
    2. empathogens
    3. dissociatives
    4. others
  12. global psychedelic drugs MARKET, BY drugs
    1. overview
    2. gamma-hydroxybutyric acid
    3. ketamine
    4. psilocybin
    5. others
  13. global psychedelic drugs MARKET, BY appplication
    1. overview
    2. narcolepsy
    3. Treatment resistant depression
    4. major depressive disorder
    5. opiate addiction
    6. post-traumatic stress disorder
    7. others
  14. global psychedelic drug market, BY route of administration
    1. overview
    2. oral
    3. inhalation
    4. injectable
  15. global psychedelic drugs MARKET, BY end user
    1. overview
    2. hospitals
    3. Specialty Clinics
    4. Homecare
    5. others
  16. global psychedelic drugs MARKET, BY distribution channel
    1. overview
    2. Hospital Pharmacy
    3. retail Pharmacy
    4. online Pharmacy
  17. GLOBAL Psychedelic Drugs MARKET, BY region
    1. Overview
    2. NORTH AMERICA
      1. u.s.
      2. canada
      3. mexico
    3. EUROPE
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. SPAIN
      6. Russia
      7. Poland
      8. Switzerland
      9. Netherlands
      10. Hungary
      11. Austria
      12. Norway
      13. Ireland
      14. Belgium
      15. Lithuania
      16. rest of europe
    4. middle east & africa
      1. Saudi Arabia
      2. israel
      3. EGYPT
      4. uae
  18. Global Psychedelic drugs market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Middle East AND Africa
  19. swot
  20. company profile
    1. JAZZ PHARMACEUTICALS, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. JANSSEN PHARMACEUTICALS, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Pfizer Inc.
      1. REVENUE ANALYSIS
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. VERRIAN
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    5. AVADEL
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. RECENT DEVELOPMENTS
    6. Celon Pharma S.A.
      1. COMPANY SNAPSHOT
      2. PIPELINE PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. COMPASS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    9. HIKMA PHARMACEUTICALS PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. neuroRX, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. PHARMATHER INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. usonainstitute.org
      1. INSTITUTE SNAPSHOT
      2. PIPELINE PORTFOLIO
      3. RECENT DEVELOPMENTS
  21. questionnaire
  22. related reports

표 목록

TABLE 1 U.S. psychedelic drugs market, company wise pipeline analysis

TABLE 2 U.S. psychedelic drugs market, Research Institute pipeline analysis

TABLE 3 Psychedelics researches, in Europe

TABLE 4 Mental Illness in the U.S. adults, in 2018

TABLE 5 Mental Disorders, in the U.S. adults, in 2018

TABLE 6 More than one in six people in EU countries have a mental health problem

TABLE 7 Men are more likely to die from suicide, in all EU countries

TABLE 8 Mental Disorders causeD by usage of substance disorders, in world, in 2017

TABLE 9 Drug Development Pathway for FDA approval of New Medications

TABLE 10 The 1971 UN Convention on Psychotropic Substances

TABLE 11 cost of psychedelic drugs

TABLE 12 Total costs (direct and indirect) of mental health problems in EU countries, in million and as a share of GDP, In 2015

TABLE 13 psychedelic drugs R&D activities

TABLE 14 Global Psychedelic drug market, By source 2020-2028 (USD Million)

TABLE 15 Global Synthetic in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 16 Global Natural in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 17 global psychedelic drug market, By Type, 2020-2028 (USD Million)

TABLE 18 Global Empathogens in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 19 Global Dissociatives in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 20 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 21 Global Therapy in Psychedelic Drugs Market, By Drugs, 2019-2028 (USD Million)

TABLE 22 Global Gamma-Hydroxybutyric Acid in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 23 Global Ketamine in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 24 Global Psilocybin in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 25 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 26 Global application in psychedelic drugs Market, By Application, 2019-2028 (USD Million)

TABLE 27 Global Narcolepsy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 28 Global Treatment Resistant Depression in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 29 Global Major Depressive Disorder in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 30 Global Opiate Addiction in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 31 Global Post-Traumatic Stress Disorder in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 32 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 33 Global Psychedelic Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 34 Global Oral in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 35 Global Inhalation in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 36 Global Injectable in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 37 global psychedelic drug market, By END USER, 2020-2028 (USD Million)

TABLE 38 Global Hospitals in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 39 Global Specialty Clinics in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 40 Global Homecare in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 41 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 42 global medication & supplements in psychedelic drug market, By distribution channel, 2020-2028 (USD million)

TABLE 43 Global Hopitals Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 44 Global Retail Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 45 Global Online Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 46 GLOBAL Psychedelic Drugs MARKET, By Region, 2018-2027 (USD million)

TABLE 47 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 48 NORTH AMERICA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICA PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 50 NORTH AMERICA PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 51 NORTH AMERICA PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 52 NORTH AMERICA PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 53 NORTH AMERICA PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 54 NORTH AMERICA PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 55 u.s.PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 56 u.s. PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 57 u.s. PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 58 u.s. PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 59 u.s. PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 60 u.s. PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 61 u.s. PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 62 canada PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 63 canada PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 64 canada PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 65 canada PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 66 canada PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 67 canada PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 68 canada PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 69 mexico PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 70 mexico PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 71 mexico PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 72 mexico PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 73 mexico PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 74 mexico PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 75 mexico PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 76 EUROPE PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 77 EUROPE PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 78 EUROPE PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 79 EUROPE PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 80 EUROPE PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 81 EUROPE PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 82 EUROPE PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 83 EUROPE PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 84 Germany PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 85 Germany PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 86 Germany PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 87 Germany PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 88 Germany PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 89 Germany PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 90 Germany PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 91 U.K. PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 92 U.K. PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 93 U.K. PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 94 U.K. PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 95 U.K. PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 96 U.K. PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 97 U.K. PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 98 France PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 99 France PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 100 France PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 101 France PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 102 France PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 103 France PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 104 France PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 105 Italy PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 106 Italy PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 107 Italy PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 108 Italy PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 109 Italy PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 110 Italy PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 111 Italy PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 112 spain PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 113 Spain PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 114 Spain PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 115 Spain PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 116 Spain PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 117 Spain PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 118 Spain PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 119 RUSSIA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 120 Russia PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 121 Russia PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 122 Russia PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 123 Russia PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 124 Russia PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 125 Russia PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 126 Poland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 127 Poland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 128 Poland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 129 Poland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 130 Poland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 131 Poland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 132 Poland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 133 Switzerland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 134 Switzerland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 135 Switzerland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 136 Switzerland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 137 Switzerland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 138 Switzerland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 139 Switzerland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 140 Netherlands PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 141 Netherlands PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 142 Netherlands PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 143 Netherlands PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 144 Netherlands PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 145 Netherlands PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 146 Netherlands PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 147 Hungary PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 148 Hungary PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 149 Hungary PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 150 Hungary PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 151 Hungary PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 152 Hungary PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 153 Hungary PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 154 Austria PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 155 Austria PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 156 Austria PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 157 Austria PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 158 Austria PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 159 Austria PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 160 Austria PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 161 Norway PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 162 Norway PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 163 Norway PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 164 Norway PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 165 Norway PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 166 Norway PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 167 Norway PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 168 Ireland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 169 Ireland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 170 Ireland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 171 Ireland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 172 Ireland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 173 Ireland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 174 Ireland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 175 Belgium PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 176 Belgium PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 177 Belgium PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 178 Belgium PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 179 Belgium PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 180 Belgium PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 181 Belgium PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 182 Lithuania PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 183 Lithuania PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 184 Lithuania PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 185 Lithuania PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 186 Lithuania PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 187 Lithuania PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 188 Lithuania PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 189 rest of europe PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 190 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 191 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 192 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 193 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 194 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 195 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 196 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 197 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 198 Saudi atrabia PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 199 Saudi Arabia PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 200 Saudi Arabia PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 201 Saudi Arabia PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 202 Saudi Arabia PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 203 Saudi Arabia PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 204 Saudi Arabia PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 205 israel PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 206 israel PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 207 israel PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 208 israel PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 209 israel PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 210 israel PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 211 israel PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 212 egypt PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 213 egypt PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 214 egypt PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 215 egypt PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 216 egypt PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 217 egypt PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 218 egypt PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 219 UAE PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 220 UAE PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 221 UAE PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 222 UAE PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 223 UAE PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 224 uae PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 225 UAE PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

그림 목록

FIGURE 1 Global PSYCHEDELIC DRUGS MARKET: SEGMENTATION

FIGURE 2 GLOBAL PSYCHEDELIC DRUGS MARKET : DATA TRIANGULATION

FIGURE 3 global Psychedelic drugs Market: DROC ANALYSIS

FIGURE 4 Global Psychedelic drugs market: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 Global Psychedelic drugs Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL Psychedelic drugs MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL Psychedelic drugs MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL PSYCHEDELIC DRUGS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL psychedelic drugs Market: MARKET APPLICATION COVERAGE GRID

FIGURE 10 GLOBAL PSYCHEDELIC DRUGS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Global Psychedelic drugs market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL Psychedelic drugs market GROWing WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION AND INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS are DRIVing THE global Psychedelic drugs MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 SYNTHETIC SEGMENT is expected to account for the largest share of the global PSYCHEDELIC DRUGS MARKET in 2021 & 2028

FIGURE 15 North america is the fastest growing market FOR Psychedelic drugs MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PSYCHEDELIC DRUGS MARKET

FIGURE 17 MENTAL ILLNESS AMONG THE U.S. ADULTS, IN 2018, BY DEMOGRAPHIC GROUP

FIGURE 18 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2018, BY DEMOGRAPHIC GROUP

FIGURE 19 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2018, BY GENDER

FIGURE 20 PREVALENCE OF MENTAL HEALTH DISORDERS BY DISORDER TYPE, IN WORLD, IN 2017

FIGURE 21 MAGIC MUSHROOMS PRICES FOR RESEARCHERS, IN THE U.S.

FIGURE 22 global psychedelic drugs market: BY source, 2020

FIGURE 23 global psychedelic drugs market: BY source, 2021-2028 (USD Million)

FIGURE 24 global psychedelic drugs market: BY source, CAGR (2021-2028)

FIGURE 25 global psychedelic drugs market: BY source, LIFELINE CURVE

FIGURE 26 global psychedelic drugs market: BY type, 2020

FIGURE 27 global psychedelic drugs market: BY type, 2021-2028 (USD Million)

FIGURE 28 global psychedelic drugs market: BY type, CAGR (2021-2028)

FIGURE 29 global psychedelic drugs market: BY type, LIFELINE CURVE

FIGURE 30 global psychedelic drugs market: BY drugs, 2020

FIGURE 31 global psychedelic drugs market: BY drugs, 2021-2028 (USD Million)

FIGURE 32 global psychedelic drugs market: BY drugs, CAGR (2021-2028)

FIGURE 33 global psychedelic drugs market: BY drugs, LIFELINE CURVE

FIGURE 34 global psychedelic drugs market: BY application, 2020

FIGURE 35 global psychedelic drugs market: BY application, 2021-2028 (USD Million)

FIGURE 36 global psychedelic drugs market: BY applicaiton, CAGR (2021-2028)

FIGURE 37 global psychedelic drugs market: BY application, LIFELINE CURVE

FIGURE 38 global psychedelic drug market: BY route of administraiton, 2020

FIGURE 39 global psychedelic drug market: BY route of administration, 2020-2028 (USD Million)

FIGURE 40 global psychedelic drug market: BY route of administration, CAGR (2020-2028)

FIGURE 41 global psychedelic drug market: BY route of administration, LIFELINE CURVE

FIGURE 42 global psychedelic drug market: BY end user, 2020

FIGURE 43 global psychedelic drug market: BY end user, 2020-2028 (USD Million)

FIGURE 44 global psychedelic drug market: BY end user, CAGR (2020-2028)

FIGURE 45 global psychedelic drug market: BY end user, LIFELINE CURVE

FIGURE 46 global psychedelic drugs market: BY distribution channel, 2020

FIGURE 47 global psychedelic drugs market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 48 global psychedelic drugs market: BY distribution channel, CAGR (2020-2028)

FIGURE 49 global psychedelic drugs market: BY distribution channel, LIFELINE CURVE

FIGURE 50 GLOBAL Psychedelic Drugs MARKET: SNAPSHOT (2020)

FIGURE 51 GLOBAL Psychedelic Drugs MARKET: BY Region (2020)

FIGURE 52 GLOBAL Psychedelic Drugs MARKET: BY Region (2020 & 2028)

FIGURE 53 GLOBAL Psychedelic Drugs MARKET: BY Region (2020 & 2028)

FIGURE 54 GLOBAL Psychedelic Drugs MARKET: BY type (2021-2028)

FIGURE 55 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)

FIGURE 56 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)

FIGURE 57 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 58 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 59 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)

FIGURE 60 EUROPE PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)

FIGURE 61 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)

FIGURE 62 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 63 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 64 EUROPE PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)

FIGURE 65 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)

FIGURE 66 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)

FIGURE 67 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 68 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 69 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)

FIGURE 70 Global Psychedelic drugs market: company share 2020 (%)

FIGURE 71 north america Psychedelic drugs market: company share 2020 (%)

FIGURE 72 europe Psychedelic drugs market: company share 2020 (%)

FIGURE 73 Middle East AND Africa Psychedelic drugs market: company share 2020 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

Rising Support for Psychedelic Therapy & Worldwide Shift Towards Psychedelic Legalization and Decriminalization are the growth drivers of the psychedelic drugs market.
Source, type, drugs, application, route of administration, end-user, and distribution channel are the factors on which the psychedelic drugs market research is based.
The major companies in the psychedelic drugs market are Jazz Pharmaceuticals, Inc. (U.S.), Janssen Pharmaceuticals, Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Compass (U.S.), Verrian (Germany), Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Avadel (Ireland), Celon Pharma SA (Poland), Cybin Corp. (Canada), GH Research (Ireland), Entheon Biomedical Corp (Canada), PharmaTher Holdings Ltd. (India), NRx Pharmaceuticals, Inc. (U.S.), and Usona Institute (U.S.).
The psychedelic drugs market size will be worth USD 7.35 billion by 2031.
The psychedelic drugs market growth rate will be 13.3% by 2031.

관련 페이지 탐색

Banner